Sells clinical genetic testing and research network access to health systems, and runs genomically stratified development programs for therapeutics companies. Founded by data science leaders from the Broad Institute and out of stealth in October 2026 with a $30M Series A.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.